
Article 1 
Member States shall, in accordance with this Decision, submit intermediate and final reports as regards eradication, control and monitoring programmes adopted pursuant to Article 24 of Decision 90/424/EEC.
Article 2 
For the purpose of this Decision, the following definitions shall apply:

((a)) ‘intermediate reports’ means intermediate technical and financial reports evaluating the running programmes, to be submitted to the Commission as provided for in Article 24(7)(a) of Decision 90/424/EEC;
((b)) ‘final reports’ means detailed technical and financial reports to be submitted to the Commission by 30 April each year at the latest for the entire year of application of the programmes, as provided for in Article 24(7)(b) of Decision 90/424/EEC;
((c)) ‘payment applications’ means the payment applications relating to the expenditure incurred by a Member State, to be submitted to the Commission, as provided for in Article 24(8) of Decision 90/424/EEC.
Article 3 

1. With regards to running programmes approved for Community co-financing in accordance with Article 24(5) of Decision 90/424/EEC, an intermediate report shall be submitted to the Commission by 31 July each year at the latest.
2. The intermediate reports shall include:
(a) in respect of bovine tuberculosis, bovine brucellosis, ovine and caprine brucellosis (B. melitensis), Enzootic Bovine Leucosis (EBL), Aujesky’s disease, Bluetongue in endemic or high risk areas, African swine fever, swine vesicular disease, classical swine fever, Anthrax, Contagious bovine pleuropneumonia, Echinococcosis, Trichinellosis, Verotoxigenic E. coli, all the relevant information, including at least, the information specified in Annexes I, II, III IV and VII, as appropriate;
(b) in respect of rabies, all the relevant information, including at least, the information specified in Annexes I and VII, as appropriate;
(c) in respect of Salmonellosis (zoonotic salmonella), all the relevant information, including at least, the information specified in Annexes I, V.A and VII as appropriate;
(d) in respect of Transmissible spongiform encephalopathies (TSE), all the relevant information, including at least, the information specified in Annex VIII, as appropriate;
(e) in respect of Avian influenza in poultry and wild birds all the relevant information, including at least, the information specified in Annex IX, as appropriate;
(f) in respect of aquaculture animal diseases such as Infectious haematopoietic necrosis (IHN), Infectious salmon anaemia (ISA), Viral haemorrhagic septicæmia (VHS), Koi herpes virus infection (KHV), Infection with Bonamia ostreae, Infection with Marteilia refringens, White spot disease in crustacean, all the relevant information, including at least, the information specified in Annex X, as appropriate.
Article 4 

1. Final reports shall include:
(a) in respect of bovine tuberculosis, bovine brucellosis, ovine and caprine brucellosis (B. melitensis), Enzootic Bovine Leucosis (EBL), Aujesky’s disease, Bluetongue in endemic or high risk areas, African swine fever, swine vesicular disease, classical swine fever, Anthrax, Contagious bovine pleuropneumonia, Echinococcosis, Trichinellosis, Verotoxigenic E. coli, the payment application and all relevant information, including at least, the information specified in Annexes II, III, IV, V, VI, VII and in the specific Annexes VII.A, VII.B, VII.C or VII.D, as appropriate;
(b) in respect of rabies, the payment application and all relevant information, including at least, the information specified in Annexes VII and VII.E, as appropriate;
(c) in respect of Salmonellosis (zoonotic salmonella), the payment application and all relevant information, including at least, the information specified in Annexes V.A, VI, VII and VII.F, as appropriate;
(d) in respect of Transmissible spongiform encephalopathies (TSE), the payment application and all relevant information, including at least, the information specified in Annexes VIII, as appropriate;
(e) in respect of Avian influenza in poultry and wild birds, the payment application and all relevant information, including at least, the information specified in Annexes IX, as appropriate;
(f) in respect of aquaculture animal diseases such as Infectious haematopoietic necrosis (IHN), Infectious salmon anaemia (ISA), Viral haemorrhagic septicæmia (VHS), Koi herpes virus infection (KHV), Infection with Bonamia ostreae, Infection with Marteilia refringens, White spot disease in crustaceans, the payment application and all relevant information, including at least, the information specified in Annex X, as appropriate.
2. For the purpose of completing the table laid down in Annexes VII C, D and F and without prejudice to Article 4(2) of Commission Regulation (EC) No 296/96, Member States should indicate in the column ‘compensation’ the compensation granted between 1 day and 90 calendar days after the slaughter of the animal or the destruction of the products or after the presentation of the completed claim by the owner. Where the authorities concerned make compensation payments outside of the 90 days (from 91 to 210 calendar days) reduction in Community financial support shall apply.
Article 5 
Decision 2002/677/EC is repealed.
Article 6 
This Decision shall apply to programmes for the eradication, control and monitoring of animal diseases to be implemented as from 1 January 2009.
Article 7 
This Decision is addressed to the Member States.
Done at Brussels, 21 October 2008.
For the Commission
Androulla VASSILIOU
Member of the Commission
ANNEX I


 Member State:
 Date:
 Disease/zoonosis:
 Animal species:
Minimum content of the evaluation:

1.. technical and financial evaluation:

1.1. confirmation that all legislation concerning the implementation of the programme was in force at the beginning of the programme (if not, evaluation of the situation);
1.2. evaluation of the implementation of budgetary requirements necessary for the running of the programme;
1.3. estimation of the money already spent in the context of the programme for the co-financed measures;
1.4. preview of the money to be spent in the whole year under report for the co-financed measures.

ANNEX II

 Member State:
 Date:
 Year:
 Disease:
 Animal species: Reporting period Intermediate report
 Final reportRegion Total number of herds Total number of herds under the programme Number of herds checked Number of positive herds Number of new positive herds Number of herds depopulated % positive herds depopulated Indicators
% herd coverage % positive herdsPeriod herd prevalence % new positive herdsHerd incidence
1 2 3 4 5 6 7 8 = (7/5) × 100 9 = (4/3) × 100 10 = (5/4) × 100 11 = (6/4) × 100
          
          
          
          
          
          
Total          
Total — 1          








ANNEX III

 Member State:
 Date:
 Year:
 Disease:
 Animal species: Reporting period Intermediate report
 Final reportRegion Total number of animals Number of animals to be tested under the programme Number of animals tested Number of animals tested individually Number of positive animals Slaughtering Indicators
Number of animals with positive result slaughtered or culled Total number of animals slaughtered % coverage at animal level % positive animals Animal prevalence
1 2 3 4 5 6 7 8 9 = (4/3) × 100 10 = (6/4) × 100
         
         
         
         
         
         
Total         
Total — 1         







ANNEX IV

 Member State:
 Date:
 Year:
 Disease:
 Species: Reporting period Intermediate report
 Final reportRegion Total number of herds Total number of animals Information on young animals vaccination programme Information on mass vaccination programme
Number of herds in vaccination programme Number of herds vaccinated Number of animals vaccinated Number of doses of vaccine administered Number of herds in vaccination programme Number of herds vaccinated Number of adults vaccinated Number of young animals vaccinated Number of doses of vaccine administered
1 2 3 4 5 6 7 8 9 10 11 12
           
           
           
           
           
           
           
Total           
Total — 1           





ANNEX V
DATA ON STATUS OF HERDS AT THE END OF THE PERIOD 




 Member State:
 Disease:
 Date:
 Species:
 Year:

Region Status of herds and animals under the programme
Total number of herds and animals under the programme Unknown Not free or not officially free Free or officially free suspended Free Officially free
Last check positive Last check negative
Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals Herds Animals
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
              
              
              
              
              
              
Total              
Total — 1              












ANNEX V.A
Intermediate technical reportFinal technical report
 Member State:
 Date:
 Year:
 Salmonella serotypes:
 Animal Species:
 Region: Reporting period Intermediate report
 Final reportType of flock Total number of flocks Total number of animals Total number of flocks under the programme Total number of animals under the programme Number of flocks checked Number of positive flocks Number of flocks depopulated Total number of animals slaughtered or destroyed Quantity of the eggs destroyed (number or kg) Quantity of eggs channelled to egg products (number or kg)
Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes Serotypes targeted in the control programme Other serotypes
               
               
               
               
               
               
               
               
               








ANNEX VI


 Member State:
 Date:
 Disease/zoonosis:
 Animal species:
Minimum content of the report:

1.. Submission of data (Annexes II, III, IV, V and Va, as appropriate)
2.. Technical evaluation of the situation:

2.1. Epidemiological maps for each disease/infection
2.2. Information on diagnostic test used (table A):

Disease/species Test Type of sample Type of test Number of tests performed
    
    



2.3. Data on infection:

Disease/species Number of herds infected Number of animals infected
  
  
2.4. Reasons for suspension the free or officially free status for each disease (table B):

Disease/species Reason Number of herds suspended
  

2.5. Achievement of targets and technical difficulties
2.6. Additional epidemiological information: information on epidemiological inquiries, abortions, lesions found in abattoir or necropsy, human cases, etc.
3.. Financial aspects:

3.1. Completed tables of Annex VII
3.2. Overview over the money spent in the context of the programme
3.3. Detailed listing of the eligible costs.

ANNEX VII

 Member State:
 Date:
 Year:
 Disease/zoonosis:
 Species: Reporting period Intermediate report
 Final reportRegion Measures eligible for co-financing
Compensation Laboratory analysis or other diagnostic test of official samples Vaccines Other (please specify) Other (please specify)
1 2 3 4 5 6
     
     
     
     
Total     

We certify that:

— this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),
— all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,
— no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,
— the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,
— control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

 Date: ...
 Name and signature of operational director: ...

ANNEX VII.A

 Member State:
 Period of reference:
 Year:
 Species:

Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Vaccination
Number of tests or laboratory analysis(type of test or analysis to be specified) Cost of tests or laboratory analysis(type of test or analysis to be specified) Number of vaccine doses and baits(type of vaccine to be specified) Cost of vaccine doses and baits(type of vaccine to be specified) Cost of distribution(type of distribution to be specified)
ELISA Other (to be specified) Other (to be specified) ELISA Other (to be specified) Other (to be specified)      
            
Total 0 0 0 0,0 0,0 0,0 0 0 0,0 0,0 0,0 0,0



ANNEX VII.B

 Member State:
 Period of reference:
 Year:
 Species:

Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Vaccination Other measures
Number of tests or laboratory analysis(type of test or analysis to be specified) Cost of tests or laboratory analysis(type of test or analysis to be specified) Number of vaccine doses(type of vaccine to be specified) Cost of vaccine doses(type of vaccine to be specified) Nature of measures(please specify) Cost of measures(please specify)
ELISA Other (to be specified) Other (to be specified) ELISA Other (to be specified) Other (to be specified)       Traps Other Traps Other
                
                
                
                
                
                
                
                
Total 0 0 0 0,0 0,0 0,0 0 0 0 0,0 0,0 0,0 0 0 0,0 0,0


ANNEX VII.C
PART 1

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Compensation
Number of compensated animals Total cost of compensated animals Cost of animals compensated by 90 calendar days Cost of animals compensated between 91 and 120 calendar days Cost of animals compensated between 121 and 150 calendar days Cost of animals compensated between 151 and 180 calendar days Cost of animals compensated between 181 and 210 calendar days Amount received for salvage (only for BB and BT)
        
        
        
        
        
        
        
        
Total 0 0,0 0,0 0,0 0,0 0,0 0,0 0,0




PART 2

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Vaccination
Number of tests or laboratory analysis(type of test or analysis to be specified) Cost of tests or laboratory analysis(type of test or analysis to be specified) Number of vaccine doses(type of vaccine to be specified) Cost of vaccine doses(type of vaccine to be specified)
ELISA Rose Bengale Complement fixation test Tuberculin test A.G.I.D. Other (to be specified) ELISA Rose Bengale Complement fixation test Tuberculin test A.G.I.D. Other (to be specified)    
                
                
                
                
                
                
                
                
Total 0 0 0 0 0 0 0,0 0,0 0,0 0,0 0,0 0,0 0 0 0,0 0,0




ANNEX VII.D
PART 1

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Compensation
Number of animals by species Cost of animals by species Total cost of compensated animals Cost of animals compensated by 90 calendar days Cost of animals compensated between 91 and 120 calendar days Cost of animals compensated between 121 and 150 calendar days Cost of animals compensated between 151 and 180 calendar days Cost of animals compensated between 181 and 210 calendar days
Sheep Goats Sheep Goats
          
          
          
          
          
          
          
Total 0 0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0



PART 2

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Vaccination
Number of tests or laboratory analysis(type of test or analysis to be specified) Cost of tests or laboratory analysis(type of test or analysis to be specified) Number of vaccine doses(type of vaccine to be specified) Cost of vaccine doses(type of vaccine to be specified)
Rose Bengale Complement fixation test Other (to be specified) Other (to be specified) Rose Bengale Complement fixation test Other (to be specified) Other (to be specified)    
            
            
            
            
            
            
            
Total 0 0 0 0 0,0 0,0 0,0 0,0 0 0 0,0 0,0



ANNEX VII.E

 Member State:
 Period of reference:
 Year:
 Species:

Region Measures eligible for co-financing
Vaccination
Number of vaccine doses and baits(type of vaccine to be specified) Cost of vaccine doses and baits(type of vaccine to be specified) Cost of distribution(type of distribution to be specified)
        
        
        
        
        
        
        
        
Total 0 0 0 0,0 0,0 0,0 0,0 0,0


ANNEX VII.F
PART 1

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Compensation
Number of animals and eggs by range of compensation Cost of animals and eggs by range of compensation Compensation made by 90 calendar days Compensation made between 91 and 120 calendar days Compensation made between 121 and 150 calendar days Compensation made between 151 and 180 calendar days Compensation made between 181 and 210 calendar days Total compensated
Destroyed animals Heat-treated animals Incubated hatching eggs Destroyed non incubated hatching eggs Heat-treated non incubated hatching eggs Destroyed animals Heat-treated animals Incubated hatching eggs Destroyed non incubated hatching eggs Heat-treated non incubated hatching eggs
                
                
                
                
                
                
                
Total 0 0 0 0 0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0 0 0,0 0,0




PART 2

 Member State:
 Period of reference:
 Year:
 Species:


Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Vaccination
Number of bacteriological tests(type of test to be specified) Cost of bacteriological tests(type of test to be specified) Number of vaccine doses(type of vaccine to be specified) Cost of vaccine doses(type of vaccine to be specified)
          
          
          
          
          
          
Total 0 0 0 0,0 0,0 0,0 0 0 0,0 0,0



ANNEX VIII

 Member State:
 Date:
 Year:
 Disease: Reporting period Intermediate report
 Final report

Table A
TSE Monitoring
Member State: Year:
Tests on bovine animals
 Number of tests Unit cost Total cost
Tests on animals referred to in Annex III, Chapter A, Part I, points 2.1.3 and 4 to Regulation (EC) No 999/2001 of the European Parliament and of the Council   
Tests on animals referred to in Annex III, Chapter A, Part I, points 2.2 to Regulation (EC) No 999/2001   
Total   
Tests on ovine animals
 Number of tests Unit cost Total cost
Tests on animals referred to in Annex III, Chapter A, Part II, point 2 to Regulation (EC) No 999/2001   
Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001   
Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001   
Tests performed according to the different requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001   
Others (specify)   
Total   
Tests on caprine animals
 Number of tests Unit cost Total cost
Tests on animals referred to in Annex III, Chapter A, Part II, point 2 to Regulation (EC) No 999/2001   
Tests on animals referred to in Annex III, Chapter A, Part II, point 3 to Regulation (EC) No 999/2001   
Tests on animals referred to in Annex III, Chapter A, Part II, point 5 to Regulation (EC) No 999/2001   
Tests performed according to the different requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001   
Others (specify)   
Tests on animals of other species
Tests on animals of other species (specify separately each species)   
Total   
Genotyping
 Number of tests Unit cost Total cost
Genotyping of animals referred to in Annex III, Chapter A, Part II, point 8.1 to Regulation (EC) No 999/2001   
Genotyping of animals referred to in Annex III, Chapter A, Part II, point 8.2 to Regulation (EC) No 999/2001   
Primary molecular testing with a discriminatory immuno-blotting
 Number of tests Unit cost Total cost
Tests on animals referred to in Annex X, Chapter C, point 3.2(c)(i) to Regulation (EC) No 999/2001   

Table B
TSE Eradication
Member State: Month: Year:BSE culling
 Number of animals Unit cost Total cost
Animals killed under the requirements of Annex VII, Chapter A, point 2.1 to Regulation (EC) No 999/2001   
Scrapie
Culling 
 Number of animals Unit cost Total cost
Animals killed under the requirements of Annex VII, Chapter A to Regulation (EC) No 999/2001   
Genotyping 
 Number of tests Unit cost Total cost
Animals genotyped under the requirements of Annex VII, Chapter A, point 2.3 to Regulation (EC) No 999/2001   
Ewes genotyped under the framework of a breeding programme referred to in Article 6a of Regulation (EC) No 999/2001   
Rams genotyped under the framework of a breeding programme referred to in Article 6a of Regulation (EC) No 999/2001   
Total   We certify that:

— this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),
— all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,
— no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,
— the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and state aid,
— control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

 Date: …
 Name and signature of operational director: …

ANNEX IX

 Member State:
 Date:
 Year:
 Disease:
 Species: Reporting period Intermediate report
 Final report
PART A:

NUTS 2 code Total number of holdings Total number of holdings sampled Number of samples per holding Total number of tests performed per method Methods of laboratory analysis
     
     
     
     
     
     
Total     






NUTS 2 code Total number of duck and geese holdings Total number of duck and geese holdings sampled Number of samples per holding Total number of tests performed per method Methods of laboratory analysis
     
     
     
     
     
     
     
     
Total     





NUTS 2 code Total number of birds sampled Total number of samples taken for active surveillance Total number of samples taken for passive surveillance
   
   
   
   
   
   
   
   
Total   


PART B:

 Member State: …
 Period of reference: …
 Year: …
 Species: …


Region Measures eligible for co-financing
Laboratory analysis and other diagnostic tests Sampling
Number of laboratory tests Cost of laboratory tests Number of samples of wild birds
ELISA AGID HI for H5/H7 Virus isolation PCR Other(to be specified) ELISA AGID HI for H5/H7 Virus isolation PCR Other(to be specified)
             
             
             
             
             
             
             
Total 0 0 0 0 0 0 0,0 0,0 0,0 0,0 0,0 0,0 0,0



We certify that:


— this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),
— all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,
— no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,
— the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,
— control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.


 Date: …
 Name and signature of operational director: …

ANNEX X

 Member State:
 Date:
 Year:
 Disease:
 Species: Reporting period Intermediate report
 Final report

PART A:


1.
1.1. Fish
  VHS IHN ISA KHV

1.2. Molluscs
  Marteilia refringens Bonamia ostrae

1.3. Crustaceans
  White spot disease



2.
2.1. Competent Authority
 

2.2. Organisation, supervision of all stakeholders involved in the programme
 

2.3. Duration of the programme
 





3.

Member State, Zone or Compartment

 Disease:
 Year:

Farm or mollusc farming area Number of samplings Number of clinical inspections Water temperature at sampling/Inspection Species at sampling Species sampled Number of animals sampled (total and by species) Number of tests Positive results of laboratorial examination Positive results of clinical inspections
         
         
         
         
         
         
Total Total




4.


 Disease:
 Year:

Member State, Zone or Compartment Total number of farms or mollusc farming areas Total number farms or mollusc farming areas under the programme Number of farms or mollusc farming areas checked Number of positive farms or mollusc farming areas Number of new positive farms or mollusc farming areas Number of farms or mollusc farming areas depopulated % positive farms or mollusc farming areas depopulated Animals removed and disposed of TARGET INDICATORS
% farms or mollusc farming areas coverage % positive farms or mollusc farming areasperiod farms or mollusc farming areas prevalence % new positive farms or mollusc farming areasfarms or mollusc farming areas incidence
1 2 3 4 5 6 7 8 = (7/5) × 100 9 10 = (4/3) × 100 11 = (5/4) × 100 12 = (6/4) × 100
           
           
           
           
           
           
Total           







PART B:

Costs related to Specification Number of units Unitary cost in EUR Total amount in EUR Community funding requested (yes/no)
1. Testing

1.1. Cost of the analysis
 Test:    
 Test:    
 Test:    
     

1.2. Cost of sampling
     
     

1.3. Other costs
     
     
2. Vaccination or treatment

2.1. Purchase of vaccine/treatment
     
     

2.2. Distribution costs
     
     

2.3. Administering costs
     
     

2.4. Control costs
     
     
3. Removal and disposal of the aquaculture animals

3.1. Compensation of animals
     
     

3.2. Transport costs
     
     

3.3. Disposal costs
     
     

3.4. Loss in case of removal
     
     

3.5. Costs from treatment of products
     
     
4. Cleansing and disinfection
     
     
5. Salaries (staff contracted for the programme only)
     
     
6. Consumables and specific equipment
     
     
7. Other costs
     
     
     
     
Total  

We certify that:

— this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Decision/Regulation (EC) No … (mention specific financing decision),
— all supporting documents relating to the expenditure are available for inspection, notably to justify the level of compensation for animals,
— no other Community contribution was requested for this programme and all revenue accruing from operations under the programme is declared to the Commission,
— the programme was executed in accordance with the relevant Community legislation, in particular the rules on competition, the award of public contracts and State aid,
— control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities.

 Date: …
 Name and signature of operational director: …
